Jiaxing AnDiCon Biotech Co.,Ltd

Quick facts

Phase 3 pipeline

• ADC189 tablet · Oncology
  ADC189 is an antibody-drug conjugate that targets a specific tumor-associated antigen to deliver cytotoxic payload directly to cancer cells.
• ADC189 tablets · Oncology
  ADC189 is an antibody-drug conjugate that targets a specific tumor-associated antigen to deliver cytotoxic payload directly to cancer cells.
• Baloxavir Marboxil tablets · Virology/Infectious Disease
  Baloxavir marboxil inhibits the influenza virus endonuclease, blocking viral cap-dependent transcription and preventing viral replication.
• Placebo of ADC189 granules
  This is a placebo control formulation used in clinical trials and contains no active pharmaceutical ingredient.
• Placebo of ADC189 tablets
  This is a placebo control formulation used in clinical trials and contains no active pharmaceutical ingredient.
• Placebo of Baloxavir Marboxil tablets · Virology/Influenza
  This is a placebo control formulation with no active pharmacological mechanism.

Phase 1 pipeline

• ADC-189 and Itraconazole
• ADC189 180mg

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Jiaxing AnDiCon Biotech Co.,Ltd portfolio CI brief
• Jiaxing AnDiCon Biotech Co.,Ltd pipeline updates RSS